NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/02/2026
Back to search
Official data from USPTO
RADIOPHARMACEUTICAL CAPITAL OF THE WORLD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RADIOPHARMACEUTICAL CAPITAL OF THE WORLD
ST13
US500000098655204Class
35
Filing
98655204
Registration
8286650
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
06/02/2026
Trademark type
Word
Nice classes
35
Filing date
07/18/2024
Registration date
06/02/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/02/2026
Last transaction
06/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/30/2025
First use in commerce
07/23/2025
Drawing code
4
Owner type
54
Owner location
Indianapolis, IN, US
Examiner
KUYKENDALL, LYNDSEY
Law office
N60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Central Indiana Corporate Partnership, Inc.
Representatives
LOUIS T. PERRY FAEGRE DRINKER BIDDLE & REATH LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting economic developmentattracting and creating jobscompaniesentrepreneurial opportunities within Indiana's life science industry
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/02/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/08/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/08/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/15/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/15/2026
IUAF
USE AMENDMENT FILED
11/04/2025
EISU
TEAS STATEMENT OF USE RECEIVED
11/04/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/13/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/18/2025
PUBO
PUBLISHED FOR OPPOSITION
03/18/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/12/2025
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/24/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/21/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/20/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/20/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/12/2025
GNRT
NON-FINAL ACTION E-MAILED
02/12/2025
CNRT
NON-FINAL ACTION WRITTEN
02/12/2025
DOCK
ASSIGNED TO EXAMINER
02/07/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/06/2025
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/24/2024
ALIE
ASSIGNED TO LIE
10/24/2024
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
07/19/2024
NWAP
NEW APPLICATION ENTERED
07/18/2024
Continuous trademark protection
Get notified about every new filing that threatens RADIOPHARMACEUTICAL CAPITAL OF THE WORLD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.